drugset / Trial / NCT00479180

Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use

NCT00479180 ↗

Phase 1/2 Completed 65 enrolled Pervasis Therapeutics, Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Vascugel™ is safe when placed at the anastomotic site at the time of surgery during creation of an AV graft or fistula for hemodialysis access.

Timeline

Start
2006-07
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Vascugel Unknown — Other

Indications

No indication recorded.